15-72662426-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_018652.5(GOLGA6B):c.1022A>G(p.Glu341Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018652.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000630 AC: 8AN: 126982Hom.: 0 Cov.: 20
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000946 AC: 12AN: 1269164Hom.: 0 Cov.: 35 AF XY: 0.00000795 AC XY: 5AN XY: 629158
GnomAD4 genome AF: 0.0000630 AC: 8AN: 126982Hom.: 0 Cov.: 20 AF XY: 0.0000816 AC XY: 5AN XY: 61284
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1022A>G (p.E341G) alteration is located in exon 11 (coding exon 11) of the GOLGA6B gene. This alteration results from a A to G substitution at nucleotide position 1022, causing the glutamic acid (E) at amino acid position 341 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at